Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVRNASDAQ:DXRNYSE:ELMDNASDAQ:INGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVRAnteris Technologies Global$3.96-1.7%$4.27$2.34▼$8.79$142.80MN/A209,487 shs7,979 shsDXRDaxor$8.68-6.6%$8.11$6.55▼$10.00$42.01M-0.136,043 shs515 shsELMDElectromed$21.52-0.6%$21.37$13.74▼$35.56$180.47M0.473,926 shs12,729 shsINGNInogen$7.06+0.1%$6.61$5.70▼$13.33$189.84M1.64241,670 shs49,797 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVRAnteris Technologies Global+6.05%+7.47%+10.71%-13.52%+402,999,900.00%DXRDaxor-1.80%+3.22%+20.03%+15.26%-0.75%ELMDElectromed+1.88%+7.87%+10.18%-9.11%+49.83%INGNInogen+5.70%+8.80%+7.96%-1.67%-11.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVRAnteris Technologies GlobalN/AN/AN/AN/AN/AN/AN/AN/ADXRDaxor3.3159 of 5 stars3.53.00.00.00.03.30.0ELMDElectromed1.1799 of 5 stars2.05.00.00.00.61.70.0INGNInogen4.3421 of 5 stars3.34.00.03.92.21.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVRAnteris Technologies Global 3.00Buy$16.50316.67% UpsideDXRDaxor 3.00Buy$25.00188.02% UpsideELMDElectromed 4.00Strong Buy$38.0076.56% UpsideINGNInogen 2.50Moderate Buy$11.0055.92% UpsideCurrent Analyst Ratings BreakdownLatest DXR, ELMD, INGN, and AVR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/16/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.006/15/2025INGNInogenB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$14.005/22/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Moderate Buy$12.005/15/2025ELMDElectromedB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy5/8/2025INGNInogenStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$10.00 ➝ $7.004/9/2025INGNInogenNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold(Data available from 6/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVRAnteris Technologies Global$2.70M52.89N/AN/A$1.74 per share2.28DXRDaxorN/AN/AN/AN/AN/AN/AELMDElectromed$61.44M2.94$0.52 per share41.36$5.10 per share4.22INGNInogen$335.70M0.57N/AN/A$7.30 per share0.97Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVRAnteris Technologies Global-$76.29MN/A0.00N/AN/AN/AN/AN/AN/ADXRDaxorN/AN/A0.00∞N/AN/AN/AN/AN/AELMDElectromed$5.15M$0.7928.69∞N/A11.34%15.71%13.37%N/AINGNInogen-$35.89M-$1.15N/AN/AN/A-8.08%-14.76%-9.01%8/5/2025 (Estimated)Latest DXR, ELMD, INGN, and AVR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025AVRAnteris Technologies GlobalN/A-$0.61N/A-$0.61N/AN/A5/7/2025Q1 2025INGNInogen-$0.52-$0.25+$0.27-$0.25$79.57 million$82.28 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVRAnteris Technologies GlobalN/AN/AN/AN/AN/ADXRDaxorN/AN/AN/AN/AN/AELMDElectromedN/AN/AN/AN/AN/AINGNInogenN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVRAnteris Technologies GlobalN/A3.673.65DXRDaxorN/AN/AN/AELMDElectromedN/A5.104.74INGNInogenN/A3.072.67Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVRAnteris Technologies GlobalN/ADXRDaxor1.34%ELMDElectromed40.82%INGNInogen89.94%Insider OwnershipCompanyInsider OwnershipAVRAnteris Technologies GlobalN/ADXRDaxor59.50%ELMDElectromed14.00%INGNInogen1.46%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVRAnteris Technologies Global13836.06 millionN/AN/ADXRDaxor374.84 million1.96 millionNot OptionableELMDElectromed1608.39 million7.36 millionOptionableINGNInogen1,03026.89 million26.49 millionOptionableDXR, ELMD, INGN, and AVR HeadlinesRecent News About These CompaniesInogen-Yuwell launch new stationary oxygen concentratorJune 25 at 12:33 AM | hmenews.comInogen-Yuwell launch new stationary oxygen concentratorJune 25 at 12:33 AM | hmenews.comInogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen TherapyJune 23 at 9:04 AM | businesswire.comWhat is B. Riley's Forecast for Inogen Q2 Earnings?June 18, 2025 | marketbeat.comB. Riley Initiates Coverage on Inogen (NASDAQ:INGN)June 18, 2025 | americanbankingnews.comInogen (NASDAQ:INGN) Upgraded by B. Riley to "Strong-Buy" RatingJune 17, 2025 | marketbeat.comInogen (INGN) Stock Coverage Initiated by B. Riley Securities | INGN Stock NewsJune 16, 2025 | gurufocus.comInogen: Still Breathing, But Margin Pressures PersistJune 16, 2025 | seekingalpha.comInogen (NASDAQ:INGN) Coverage Initiated by Analysts at B. RileyJune 16, 2025 | marketbeat.comInogen (INGN) Initiated with Buy Rating by B. Riley Analyst | INGN Stock NewsJune 16, 2025 | gurufocus.comInogen (INGN) Receives Buy Rating and $14 Target from B. Riley | INGN Stock NewsJune 15, 2025 | gurufocus.comHere’s Why Brown Capital Management Small Company Fund Sold Inogen (INGN) in Q1June 10, 2025 | insidermonkey.comTwo Sigma Advisers LP Lowers Holdings in Inogen, Inc. (NASDAQ:INGN)June 8, 2025 | marketbeat.comInogen (INGN) Down 0.8% Since Last Earnings Report: Can It Rebound?June 7, 2025 | msn.com46,224 Shares in Inogen, Inc. (NASDAQ:INGN) Purchased by Squarepoint Ops LLCJune 5, 2025 | marketbeat.comMillennium Management LLC Acquires 88,924 Shares of Inogen, Inc. (NASDAQ:INGN)June 5, 2025 | marketbeat.comWith 72% ownership of the shares, Inogen, Inc. (NASDAQ:INGN) is heavily dominated by institutional ownersMay 30, 2025 | finance.yahoo.comHere's Why You Should Add Inogen Stock to Your Portfolio NowMay 28, 2025 | zacks.comZacks.com featured highlights Urban Outfitters, Inogen and Southwest GasMay 28, 2025 | finance.yahoo.com3 Stocks With Upgraded Broker Ratings to Bet on Amid UncertaintiesMay 27, 2025 | zacks.comD. E. Shaw & Co. Inc. Sells 77,489 Shares of Inogen, Inc. (NASDAQ:INGN)May 26, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDXR, ELMD, INGN, and AVR Company DescriptionsAnteris Technologies Global NASDAQ:AVR$3.96 -0.07 (-1.74%) As of 11:07 AM EasternAnteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.Daxor NASDAQ:DXR$8.68 -0.61 (-6.57%) As of 09:49 AM EasternDaxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.Electromed NYSE:ELMD$21.52 -0.13 (-0.59%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.Inogen NASDAQ:INGN$7.06 +0.01 (+0.07%) As of 11:35 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Costco at a Crossroads: Is the Next Move Higher or Lower? AST SpaceMobile's Signal Strengthens as Stock Nears Orbit Oracle Stock Boils Higher, $300 Price Target in Sight 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Which Analyst-Favorite Drone Stock Will Come Out on Top? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
